As of May 23
| -0.24 / -0.52%|
The 27 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 48.13, with a high estimate of 58.16 and a low estimate of 36.25. The median estimate represents a +5.06% increase from the last price of 45.81.
The current consensus among 30 polled investment analysts is to Hold stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since May, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.